Adoption of the SteriSpine PS pedicle screw and SteriSpine VA vertebral augmentation balloon contributed to growth, as did continued training of newly recruited sales representatives
Direct sales in France, Germany and the U.K. decreased by -7% in the quarter, while indirect sales via distributors increased 124%
In late September 2019, the company announced recruitment of a new VP of Strategy and Marketing as well as a Director of Sales for the French and U.K. markets to reinvigorate the direct salesforce
ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).
3Q19
3Q18
$ Chg
% Chg
Spine
$1.3
$0.9
$0.4
40.8%
9mo 19
9Mo 18
$ Chg
% Chg
Spine
$3.6
$2.8
$0.8
29.6%
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
Adoption of the SteriSpine PS pedicle screw and SteriSpine VA vertebral augmentation balloon contributed to growth, as did continued training of newly recruited sales representatives Direct sales in France, Germany and the U.K. decreased by...
Adoption of the SteriSpine PS pedicle screw and SteriSpine VA vertebral augmentation balloon contributed to growth, as did continued training of newly recruited sales representatives
Direct sales in France, Germany and the U.K. decreased by -7% in the quarter, while indirect sales via distributors increased 124%
In late September 2019, the company announced recruitment of a new VP of Strategy and Marketing as well as a Director of Sales for the French and U.K. markets to reinvigorate the direct salesforce
ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).
3Q19
3Q18
$ Chg
% Chg
Spine
$1.3
$0.9
$0.4
40.8%
9mo 19
9Mo 18
$ Chg
% Chg
Spine
$3.6
$2.8
$0.8
29.6%
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
